Spleen removal during pancreas surgery for severe pancreatitis
Part of Digestive system clinical trials.
This trial tests whether removing the spleen during open surgery for infected dead pancreas tissue helps people with a specific type of high blood pressure around the spleen caused by severe pancreatitis. It may lower bleeding risk and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have acute necrotizing pancreatitis (a severe type of pancreas inflammation with tissue death)
- You also have sinistral portal hypertension (high blood pressure in the veins around the spleen from pancreatitis)
- You are scheduled for open surgery to remove infected dead pancreas tissue
- You did not have organ failure, cirrhosis, or a blood disease before getting pancreatitis
- You are not having a laparoscopic or nephroscopic (scope-based) debridement
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether a minimally invasive spleen surgery (with a specific vein-disconnection procedure) can better protect liver function in people with cirrhosis who have had variceal bleeding. It may help reduce stress on the liver after treatment, but you must meet several safety criteria.
This trial tests a surgical technique to remove benign or low-risk pancreatic tumors from the head or neck of the pancreas while temporarily blocking blood flow to reduce bleeding. It may help patients avoid more extensive surgery.
This trial looks at how organ function changes in patients with severe pancreatitis and sepsis after open surgery to remove dead tissue (necrosectomy). It aims to understand if recovery patterns differ.
This study looks at how a surgery to remove dead tissue from the pancreas (called open necrosectomy) affects organ function in patients with acute pancreatitis and sepsis. It may help doctors understand how to better treat this serious condition.
This study tests a special surgery using a nerve-guided technique to remove the enlarged spleen and reduce bleeding risk in people with cirrhosis and portal hypertension. It may help if you have an enlarged spleen and have had bleeding related to liver disease.
This study tests whether removing an enlarged spleen during minimally invasive surgery can help protect kidney function in people with cirrhosis (liver scarring). Researchers will follow participants for 2 years to see how the surgery affects their kidneys.
Hear when a new Acute Necrotizing Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.